✦ LIBER ✦

230: Fludarabine/full dose I.V. busulfan conditioning regimen in allogeneic PBSC transplantation for high risk patients

✍ Scribed by S. Chunduri; L.C. Dobogai; D. Peace; Y. Saunthararajah; J. Quigley; Y.-H. Chen; P. Boccuni; R. Hoffman; N. Mahmud; R. Beri; E. Hurter; D. Rondelli

Book ID: 116279411
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 52 KB
Volume: 13
Category: Article
ISSN: 1083-8791
DOI: 10.1016/j.bbmt.2006.12.235

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Fludarabine and busulfan as a myeloablat

Fludarabine and busulfan as a myeloablative conditioning regimen for allogeneic stem cell transplantation in high- and standard-risk leukemic patients

✍ Iravani, M; Evazi, M R; Mousavi, S A; Shamshiri, A R; Tavakoli, M; Ashouri, A; S 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 146 KB

Reduced intensity conditioning regimen w

Reduced intensity conditioning regimen with fludarabine, busulfan, and low-dose TBI (Flu-BU2-TBI): Clinical efficacy in high-risk patients

✍ Mutsumi Takahata; Satoshi Hashino; Kohei Okada; Masahiro Onozawa; Kaoru Kahata; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 159 KB

## Abstract Reduced intensity conditioning (RIC) regimens are widely used in allogeneic stem cell transplantation (SCT). In this study, we retrospectively investigated the clinical outcomes of RIC with fludarabine (Flu; 180 mg/m^2^), intravenous busulfan (BU; 6.4 mg/kg) or oral BU (8 mg/kg), and lo

High-dose busulfan and cyclophosphamide

High-dose busulfan and cyclophosphamide are an effective conditioning regimen for allogeneic bone marrow transplantation in chemosensitive multiple myeloma

✍ Cavo, M; Bandini, G; Benni, M; Gozzetti, A; Ronconi, S; Rosti, G; Zamagni, E; Le 📂 Article 📅 1998 🏛 Nature Publishing Group 🌐 English ⚖ 55 KB

Successful Half-Dose Busulfan/Full-Dose

Successful Half-Dose Busulfan/Full-Dose Fludarabine Based Reduced Intensity Conditioning In High-Risk Pediatric And Adult Chronic Granulomatous Disease (CGD) Patients

✍ T. Güngör; U. Schanz; R. Seger; M. Albert; M. Hassan 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 73 KB

Fludarabine, Antithymocyte Globulin, and

Fludarabine, Antithymocyte Globulin, and Very Low-Dose Busulfan for Reduced-Intensity Conditioning before Allogeneic Stem Cell Transplantation in Patients with Lymphoid Malignancies

✍ Florent Malard; Xavier Cahu; Aline Clavert; Eolia Brissot; Patrice Chevallier; T 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 232 KB

Upfront Allogeneic Blood Stem Cell Trans

Upfront Allogeneic Blood Stem Cell Transplantation for Patients with High-Risk Myelodysplastic Syndrome or Secondary Acute Myeloid Leukemia Using a FLAMSA-Based High-Dose Sequential Conditioning Regimen

✍ Christian Saure; Thomas Schroeder; Fabian Zohren; Anke Groten; Ingmar Bruns; Ako 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 305 KB